Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma

INTRODUCTION: Real-world data on recurrence and economic burden in patients with resected early-stage melanoma are limited. The objective of this study was to assess real-world recurrence rates, risk factors for recurrence, and costs of recurrence in patients with resected stage IIB, IIC, or IIIA me...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Sekwon, Poretta, Tayla, Bhagnani, Tarun, Harshaw, Qing, Burke, Matthew, Rao, Sumati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477064/
https://www.ncbi.nlm.nih.gov/pubmed/32548707
http://dx.doi.org/10.1007/s13555-020-00404-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477064/
https://www.ncbi.nlm.nih.gov/pubmed/32548707
http://dx.doi.org/10.1007/s13555-020-00404-9

Ejemplares similares